Global EPA & DHA Market (2021 to 2026) – Growth, Trends, COVID-19 Impact and Forecasts –

DUBLIN, November 03, 2021 –( BUSINESS WIRE )–The "EPA & DHA Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)" report has been added to’s offering.

The global EPA & DHA market is projected to grow at the CAGR of 8.26% during the forecast period (2021 – 2026).

Companies Mentioned Koninklijke DSM NV

The Archer Daniels Midland Company

Corbion NV

Neptune Wellness Solutions


Croda International PLC

Pelagia AS

Golden Omega SA

Arctic Nutrition

Wiley Companies (Organic Tech)

Key Market Trends Docosahexaenoic Acid (DHA) Dominated the Market by Type The DHA segment is majorly driven by the rising demand and its incorporation in infant formulae and nutritional products targeting children’s health, as it is an essential building block for the growth and maturation of an infant’s brain and retina. It is mostly obtained from fish and algae oils. Additionally, it is extensively used in fortified foods and dietary supplements, where it is majorly used for treating Type 2 diabetes, coronary artery disease (CAD), dementia, and attention deficit-hyperactivity disorder (ADHD). The healthy aging-related benefits of DHA have also led to their successful utilization in geriatric nutrition products. Furthermore, an increasing number of product launches across the world is favoring the industry growth. For instance, Organic Technologies, in 2017, launched two new DHA omega-3 concentrates to its line of AlaskOmega fish oils and concentrates – a high DHA concentrate, and a medium strength DHA (non-tuna) tuna oil alternative. North America Dominated the EPA & DHA Market The North America EPA and DHA ingredients market is primarily driven by innovations, both, in products and technologies. The leading players are investing in technological advancements, in order to get develop improved omega ingredients for wider applications. In October 2016, DSM launched a new process technology, 3C technology. The technology aids the manufacturers of omega-3 to produce highly concentrated ingredients (up to 85%). It also facilitates the manufacturers to customize the combinations of EPA and DHA for their application in pharmaceutical and dietary supplements. The trend of consumption of supplements instead of functional food is predominant in the region. Consumers prefer high concentrated dietary supplements to meet their nutritional requirements of DHA/EPA. Thus, driving the ingredient sector’s growth in the region.

Leave a Reply

Your email address will not be published. Required fields are marked *